Aims Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to angiotensin
converting enzyme 2 (ACE2) enabling entrance of the virus into cells and causing the …

Objectives Angiotensin-converting enzyme 2 (ACE2) represents the primary receptor for
SARS-CoV-2 to enter endothelial cells. Here we investigated circulating ACE2 activity to …

COVID-19 pandemic is caused by the novel coronavirus SARS-CoV-2. Angiotensin-
converting enzyme 2 (ACE2) is not only an enzyme but also a functional receptor on cell …

Methods We measured enzymatically active plasma ACE2 concentration (subsequently
referred to as “ACE2”) and key RAS metabolites in 532 blood samples obtained from 126 …

Since the first cases of atypical pneumonia linked to the Huanan Seafood Wholesale Market
in Wuhan, China, were described in late December 2019, the global landscape has …

Angiotensin-Converting Enzyme 2 (ACE2) has been proved to be the main host cell receptor
for the binding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the …

Endothelial cells express surface angiotensin-converting enzyme 2 (ACE2), the main
receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that promotes …

Abstract Angiotensin‐converting enzyme 2 (ACE2) has been established as the functional
host receptor for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus …

Coronavirus disease 2019 (COVID-19) causes persistent endothelial inflammation, lung,
cardiovascular, kidney and neurological complications, and thromboembolic phenomena of …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) employs angiotensin-
converting enzyme 2 (ACE2) as its receptor for cell entrance, and studies have suggested …